AIM System Limited 準級

The overseas investment arm of IMM Investment Corp (http://imm.co.kr/).

IMM Investment Corp. is a leading investment manager in Korea specializing in buyout, corporate private equity, infrastructure and venture capital investment opportunities with 60+ fully dedicated professionals in 4 offices across 3 countries. As of June 2021, IMM Investment Corp. manages over US $4.7 billions of assets. As its next growth chapter, IMM is strongly pursuing geographic expansion into overseas markets through affiliates to drive future growth of IMM.

Since forming the HK licensed entity in 2019, IMMG is rapidly implementing its rollout plan by executing investments (2019/2020: Texas Express Pipeline, Brazos Midstream), raising new funds (2021: Clean Energy Transition Fund, Nahda Venture Debt Fund), and providing our overseas expertise to select Korean institutions (2020/2021: M&A and capital markets advisory). 

IMMG is leveraging its extensive transaction experience in the U.S. market and longstanding relationships with Korean investment managers to serve as the driving force in further penetrating Korean presence into the global investment arena.

We are the authorized sole agent in Hong Kong for products manufactured by Global Industry Leaders Including ITO Co Ltd, Nustep Inc, Happersberger Otopront GmbH, Sutter Medizintechnik GmbH.

Super-Medic Co has been established since 1996. Our customer base includes government and private hospitals in Hong Kong as well as local universities, government laboratories, physician clinics, physiotherapy clinics, and other medical facilities.

Greater purchasing power has allowed Super-Medic Company to be the leader in providing competitive priced supplies to our clients.